Financial News · Live Terminal

Page 663 of 752

Hin Sang Names CEO

Hin Sang Group (International) (HKG:6893) named acting Chair Kwan Lai Man as its new CEO, according to a Monday Hong Kong bourse filing.Kwan will retain her role as acting chairperson following the appointment.

HKG:6893

Asia68d ago

Luye Pharma Enrolls First Patient in Tardive Dyskinesia Drug Trial in the US

Luye Pharma (HKG:2186) enrolled the first subject in a US pharmacokinetic (PK) clinical trial of its LY03015, according to a Monday Hong Kong bourse filing.The drug is intended to treat tardive dyskinesia and Huntington's disease.

HKG:2186

Asia68d ago

Huitongda Network Completes Hong Kong-Listed Share Full Conversion

Huitongda Network (HKG:9878) completed the conversion of 349.7 million domestic shares into Hong Kong-listed shares on Monday, according to a same-day Hong Kong bourse filing.The listing of the converted shares on the Hong Kong bourse will begin at 9:00 am on Tuesday, April 21.The logistics company now has 94.21% Hong Kong-listed shares and 5.79% domestic shares.

HKG:9878

Asia68d ago

Han's CNC Technology Profit Surges 177% in Q1

Shenzhen Han's CNC Technology (HKG:3200, SHE:301200) recorded an attributable profit of 322.9 million yuan in the first quarter of 2026, up 177% from 116.8 million yuan a year prior, according to a Monday Hong Kong bourse filing.Earnings per share for the three months increased to 0.71 yuan from 0.28 yuan previously.Revenue soared 104% to 1.96 billion yuan from 959.8 million yuan in the year-ago period.

HKG:3200SHE:301200

Asia68d ago

CSPC Pharma Unit's Tumor Drug Reaches Primary Efficacy Endpoint

CSPC Pharmaceutical (HKG:1093) said the phase Ib/III clinical study of Sirolimus for Injection (Albumin-bound) met its pre-specified primary efficacy endpoint, showing statistically significant differences and clear clinical benefits, according to a Monday Hong Kong bourse filing.The drug was developed by CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang), a unit of the company for the treatment of advanced malignant perivascular epithelioid cell tumour.

HKG:1093

Asia68d ago

ICBC Sells 30 Billion Yuan Bonds

Industrial and Commercial Bank of China (HKG:1398, SHA:601398) or ICBC completed the issue of 30 billion yuan of undated bonds in the National Interbank Bond Market, according to a Monday Hong Kong bourse filing.The bonds have a distribution rate of 2.01% during the first five years, after which it will be adjusted every five years.The firm will have conditional redemption rights on each distribution payment date from the fifth anniversary.The lender will use the proceeds to replenish its additional tier 1 capital.

HKG:1398SHA:601398

Asia68d ago

Billionbrains Garage Ventures' Consolidated Profit Doubles in Fiscal Q4

Billionbrains Garage Ventures' (NSE:GROWW, BOM:544603) consolidated attributable profit more than doubled to 6.86 billion Indian rupees in the fiscal fourth quarter ended March 31, from 3.09 billion rupees a year ago.Earnings per share climbed to 1.09 rupees from 0.54 rupees a year earlier, according to a filing to the Indian bourses on Monday.Revenue from operations of the parent company of digital investment platform Groww also jumped to 15.1 billion rupees from 8.01 billion rupees a year ago.

BOM:544603NSE:GROWW

Asia68d ago

China First Capital's Winding-Up Hearing Adjourned to July 20

China First Capital (HKG:1269) said the Hong Kong High Court adjourned the hearing of a winding-up petition against it to July 20 from April 20, according to a Monday Hong Kong bourse filing.The automotive, education, and financial services company was slapped with the winding-up petition as it allegedly owes HK$10 million to a bondholder.

HKG:1269

Asia68d ago

Bank of Maharashtra Fiscal Q4 Consolidated Net Profit Rises

Bank of Maharashtra (NSE:MAHABANK, BOM:532525) posted an increase in its consolidated net profit to 20.4 billion Indian rupees in the fiscal fourth quarter ended March 31, against 15.02 billion rupees a year ago.Earnings per share climbed to 2.66 rupees compared with a year-ago figure of 1.95 rupees, according to a Monday filing to the Indian stock exchanges.Interest earned by the lender in fiscal Q4 also jumped to 77.6 billion rupees from 67.3 billion rupees a year earlier.

BOM:532525NSE:MAHABANK

Asia68d ago

Bank of Maharashtra Declares Final Dividend

Bank of Maharashtra (NSE:MAHABANK, BOM:532525) declared a final dividend of 1.20 rupees per equity share of 10 rupees each for the financial year ended March 31.

BOM:532525NSE:MAHABANK

Asia68d ago

Elife Holdings Extends Long Stop for Share Placing

Elife Holdings (HKG:0223) further extended the long stop date of a share placing agreement to May 12 from April 21, according to a Monday Hong Kong bourse filing.The extension came as the placing agent needed more time to finalize the placing with potential investors.The firm had, in January, agreed to place up to 271.2 million new shares at HK$0.102 to raise roughly HK$27.1 million in net proceeds.

HKG:0223

Asia68d ago

CGS International Downgrades Thai Airways International to Hold from Add; Price Target is THB6.40

BKK:THAI

Asia68d ago

Phillip Securities Upgrades PTT Exploration and Production to Buy from Accumulate; Price Target is THB40

BKK:PTTEP

Asia68d ago

UOB Kay Hian Upgrades KCE Electronics to Buy from Sell; Price Target is THB32

BKK:KCE

Asia68d ago

Raasi Refractories CFO Resigns

Refractory items manufacturer, Raasi Refractories (BOM:502271) said Chief Financial Officer Sistla Subrahmanya Sastry has resigned, effective April 20, citing personal reasons, according to a same-day filing on BSE.

BOM:502271

Asia68d ago

Sino Biopharmaceutical Unit Gets China Nod to Market Cancer Drug

Sino Biopharmaceutical (HKG:1177) said Benmelstobart in combination with Anlotinib obtained marketing approval from China's National Medical Products Administration, according to a Monday Hong Kong bourse filing.The approval is for the treatment of advanced or unresectable alveolar soft part sarcoma.Benmelstobart and Anlotinib are category 1 innovative drugs developed by Chia Tai Tianqing Pharmaceutical Group, a unit of the company.

HKG:1177

Asia68d ago

Guoguang Electric Chairman Steps Down

Guoguang Electric (SHE:002045) Chairman Lu Hongda stepped down due to health reasons, according to a Monday disclosure to the Shenzhen bourse.

SHE:002045

Asia68d ago

CGN Power Subsidiary's Unit 1 Qualifies for Commercial Operation

CGN Power (HKG:1816, SHE:003816) said Unit 1 of subsidiary CGN Huizhou Nuclear Power completed commissioning works April 19 and is qualified for commercial operation, according to a Monday Hong Kong bourse filing.The unit will obtain the relevant certificates, such as the Electric Power Business Permit.After Huizhou Unit 1 is put into commercial operation, the power company will have 29 nuclear power generating units in operation that it manages, with their installed capacity increasing to 33,040 megawatts from 31,838 megawatts.

HKG:1816SHE:003816

Asia68d ago

Genimous Technology Chairman Steps Down

Genimous Technology (SHE:000676) Chairman Lu Hongda stepped down due to health reasons, according to a Monday filing with the Shenzhen bourse.Lu will stay on as adviser and expressed willingness to be reelected, the filing said.

SHE:000676

Asia68d ago

Hang Zhou Iron & Steel Expects Up to 20 Billion Yuan in Daily Related-Party Transactions in 2026

Hang Zhou Iron & Steel (SHA:600126) forecasts its daily related-party transactions will reach 20 billion yuan in 2026, according to a Saturday filing with the Shanghai bourse.

SHA:600126

Showing 13241-13260 of 15033